GSK

News

GSK bags breakthrough status for B7-H3 ADC for lung cancer

An antibody-drug conjugate (ADC) that GSK licensed from China's Hansoh Pharma in a $1.7 billion deal last year has been given breakthrough status by the FDA.

News

GSK bags sought-after Jemperli okay in endometrial cancer

The FDA has cleared GSK's PD-1 inhibitor Jemperli as a treatment for all adult patients with primary advanced or recurrent endometrial cancer, a key part of the company's growth ambitions f

News

GSK raises forecasts for 2024, but shares slide

GSK posted a healthy 13% increase in second-quarter sales this morning and raised its forecasts for the year on the back of gains for its cancer and HIV drugs, beating market expectations.

News

GSK joins Flagship's flotilla of pharma partners

Flagship Pioneering has signed yet another strategic-level deal with a big pharma group, with GSK the latest to tap into its network of biotech companies in an alliance that could be worth

News

Shingles shot could be a simple way to delay dementia

Vaccination with GSK's recombinant shingles vaccine, Shingrix, could delay the onset of dementia, according to researchers in the UK.

News

GSK's Dovato matches rival Biktarvy with less weight gain

GSK has fired a shot across the bows of Gilead Sciences' HIV juggernaut Biktarvy, with new data showing its rival therapy Dovato is as effective but causes less weight gain.

GSK bags breakthrough status for B7-H3 ADC for lung cancer

GSK bags sought-after Jemperli okay in endometrial cancer

GSK raises forecasts for 2024, but shares slide

GSK joins Flagship's flotilla of pharma partners

Shingles shot could be a simple way to delay dementia

GSK's Dovato matches rival Biktarvy with less weight gain

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

GSK

Editor's Picks